Hermance Beaud
Sessions in which Hermance Beaud attends
11:30 AM
11:30 AM
- Targeting adipogenesis with green tea derived catechins: An impact on the paracrine regulation of triple-negative breast cancer progression
- Presenter Mma narjara gonzalez (UQAM) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- Targeting adipogenesis with green tea derived catechins: An impact on the paracrine regulation of triple-negative breast cancer progress...
- Allele-specific CRISPR/Cas9 cleavage approach for two epidermolysis bullosa simplex mutations
- Presenter Mbarka Bchetnia (UQAC) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- Allele-specific CRISPR/Cas9 cleavage approach for two epidermolysis bullosa simplex mutations Mbarka Bchetnia1,2
- An alkaloid extracted from the senegalese flora inhibits replication of the dengue virus genomic RNA
- Presenter Lionel Berthoux (UQTR) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- An alkaloid extracted from the senegalese flora inhibits replication of the dengue virus genomic RNA Seydou Ka1*
- L’interaction entre progéniteurs fibro-adipogéniques et médiateurs lipidiques, le nouvel orchestre de la régénération musculaire
- Presenter Thomas Molina (CR-CHU Sainte-Justine) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- L’interaction entre progéniteurs fibro-adipogéniques et médiateurs lipidiques, le nouvel orchestre de la régénération musculaire
- Design of Self-Assembled Synthetic Nanorods for Vaccine Applications
- Presenter Mélanie Côté-Cyr (UQAM) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- Design of Self-Assembled Synthetic Nanorods for Vaccine Applications Ximena Zottiga,b,d, Mélanie Côté-Cyr...
- Développement d’une nouvelle thérapie ciblée contre les cancers du sein hormono-dépendants et chimiorésistants à base des hybrides œstrogène-platine et des agents anti-inflammatoires
- Presenter Yassine Oufqir (UQTR) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- Développement d’une nouvelle thérapie ciblée contre les cancers du sein hormono-dépendants et chimiorésistants à base des hybrides œstro...
- Impact de l'hémine sur la résorption osseuse médiée par les ostéoclastes
- Presenter Nicolas Pouderous (UQAM) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- Impact de l'hémine sur la résorption osseuse médiée par les ostéoclastes Nicolas Pouderous1, Tatiana Sco...
- Session 2: Mosaic of projects
- 11:30 AM - 12:30 PM | 1 hour
- Discover the CERMO-FC members' projects in videos.In a free session, watch the videos of your choice in the mosaic and ask your questions to th...
- Effet de l’ajout exogène de résolvines sur la fonction des cellules souches musculaires en dystrophie myotonique de type 1.
- Presenter / / / / |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- Effet de l’ajout exogène de résolvines sur la fonction des cellules souches musculaires en dystrophie myotonique de type 1.
- ALS gene, C9orf72, loss of function Zebrafish model shows motor and synaptic defects
- Presenter Zoé Butti (INRS) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- ALS gene, C9orf72, loss of function Zebrafish model shows motor and synaptic defects Zoé Butti1, Jean Giacomo...
- The sigma-1 receptor: a molecular hub for psychostimulant drugs in the nucleus accumbens
- Presenter Victoria Le Corvec (UQAM) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- The sigma-1 receptor: a molecular hub for psychostimulant drugs in the nucleus accumbens
- Développement des mélanocytes dans le syndrome de Waardenburg-Shah
- Presenter Grégoire Bonnamour (UQAM) |
- 11:30 AM - 12:30 PM | 1 hour Part of: Session 2: Mosaic of projects
- Développement des mélanocytes dans le syndrome de Waardenburg-Shah Grégoire Bonnamour1,2, Nicolas P...
2:00 PM
2:00 PM
- Session 3: The research of the members
- 2:00 PM - 3:45 PM | 1 hour 45 minutes
- CERMO-FC students present you their research. A live oral and written question period will follow the presentation.Please...
- Talk
3:45 PM
3:45 PM
- Closing words from the Director
- 3:45 PM - 4:00 PM | 15 minutes
- Talk